Discover how QbD Group helped a global pharmaceutical company address fluctuating validation demands across multiple teams.
A global pharmaceutical leader specializing in sterile manufacturing and biopharmaceutical production faced fluctuating validation demands across multiple teams. To maintain compliance and operational efficiency, the client required a scalable external team to adapt to shifting workloads. QbD Group deployed 12 validation engineers, managed by a dedicated Single Point of Contact (SPOC), ensuring seamless collaboration, resource scalability, and regulatory compliance across validation processes.
The client is a global pharmaceutical leader specializing in innovative medicines and cutting-edge therapies. Its site plays a critical role in sterile manufacturing and biopharmaceutical production for global markets.
With process validation, sterilization validation, and software validation spanning multiple teams, the client faced fluctuating validation demands. To maintain compliance and operational efficiency, they required a scalable external team capable of adapting to shifting workloads while ensuring quality and regulatory standards were met.
To address this challenge, QbD Group deployed 12 validation engineers, managed by a dedicated Single Point of Contact (SPOC) to ensure seamless collaboration and adaptability. The approach included:
By implementing this flexible and structured approach, the client achieved:
✅ Seamless validation support that scales with changing demands
✅ Regulatory compliance across all validation processes
✅ Operational continuity through optimized resource allocation
继续阅读
成功案例Discover how QbD Group helped a pharmaceutical facility in Barcelona optimize and validate a complex autoclave load, improving sterilization efficiency and manufacturing flexibility.
阅读更多
成功案例Discover how QbD Group supported a global biotech company in commissioning and qualifying two ATMP therapy production sites, ensuring compliance and efficiency.
阅读更多
成功案例QbD Group has facilitated the launch of a new drug production line for treating hemophilia, overseeing the qualification of over 100 pieces of small-scale supporting equipment.
阅读更多